Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

Finasteride may reduce bleeding after TURP, but more research needed.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

PRP shows promise in musculoskeletal rehabilitation but needs standardized reporting for better outcomes.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Women with mixed alopecia have more severe mental health issues than those with metabolic alopecia.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

Ayurvedic medicine helped increase a young woman's hemoglobin levels and improved her anemia symptoms.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Early intervention and patient education are crucial for managing alopecia areata.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Effective PCOS treatments require targeting specific signaling pathways.